Johnson & Johnson (JNJ) Stock Near Record Highs: What to Know Before the Market Opens on December 8, 2025
Johnson & Johnson closed Friday at just over $201, near its 52-week high of $207.81, with a market cap around $486 billion. The company reported positive CAR-T therapy data at ASH 2025 and gained access to China’s new drug reimbursement catalog. The board declared a Q4 dividend of $1.30 per share. About 67,670 federal talc lawsuits remain unresolved after a judge rejected J&J’s latest $10 billion settlement offer.